These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 32423095)
1. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues. Darbani B Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32423095 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094 [TBL] [Abstract][Full Text] [Related]
4. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein. Calcagnile M; Forgez P; Iannelli A; Bucci C; Alifano M; Alifano P Biochimie; 2021 Jan; 180():143-148. PubMed ID: 33181224 [TBL] [Abstract][Full Text] [Related]
5. Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection. Wang J; Xu X; Zhou X; Chen P; Liang H; Li X; Zhong W; Hao P J Gen Virol; 2020 Sep; 101(9):921-924. PubMed ID: 32538738 [TBL] [Abstract][Full Text] [Related]
6. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients. Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902 [TBL] [Abstract][Full Text] [Related]
7. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Pan F; Xiao X; Guo J; Song Y; Li H; Patel DP; Spivak AM; Alukal JP; Zhang X; Xiong C; Li PS; Hotaling JM Fertil Steril; 2020 Jun; 113(6):1135-1139. PubMed ID: 32482249 [TBL] [Abstract][Full Text] [Related]
8. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141 [TBL] [Abstract][Full Text] [Related]
9. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Vargas-Alarcón G; Posadas-Sánchez R; Ramírez-Bello J Life Sci; 2020 Nov; 260():118313. PubMed ID: 32835700 [TBL] [Abstract][Full Text] [Related]
10. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. Hou Y; Zhao J; Martin W; Kallianpur A; Chung MK; Jehi L; Sharifi N; Erzurum S; Eng C; Cheng F BMC Med; 2020 Jul; 18(1):216. PubMed ID: 32664879 [TBL] [Abstract][Full Text] [Related]
11. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Chen J; Jiang Q; Xia X; Liu K; Yu Z; Tao W; Gong W; Han JJ Aging Cell; 2020 Jul; 19(7):. PubMed ID: 32558150 [TBL] [Abstract][Full Text] [Related]
12. Gene expression and Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206 [TBL] [Abstract][Full Text] [Related]
13. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation. Alshahawey M; Raslan M; Sabri N Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573 [No Abstract] [Full Text] [Related]
14. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Gkogkou E; Barnasas G; Vougas K; Trougakos IP Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle. Henarejos-Castillo I; Sebastian-Leon P; Devesa-Peiro A; Pellicer A; Diaz-Gimeno P Fertil Steril; 2020 Aug; 114(2):223-232. PubMed ID: 32641214 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651 [TBL] [Abstract][Full Text] [Related]
17. Expression Pattern of the SARS-CoV-2 Entry Genes Liu Y; Qu HQ; Qu J; Tian L; Hakonarson H Viruses; 2020 Oct; 12(10):. PubMed ID: 33081421 [TBL] [Abstract][Full Text] [Related]
18. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century. Asrani P; Hasan GM; Sohal SS; Hassan MI OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573 [TBL] [Abstract][Full Text] [Related]
19. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients. Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]